Evidence map›Paper›PMID 33633450›Full record

ArticleInternational journal of nanomedicine2021

Silver Nanoparticles Attenuate the Antimicrobial Activity of the Innate Immune System by Inhibiting Neutrophil-Mediated Phagocytosis and Reactive Oxygen Species Production.

Moran Huang, Kai Ye, Tu Hu, Kexin Liu, Mengzhen You, Lei Wang, Hui Qin

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. An in vitro study on macrophage toxicity of allotrope silver nanoparticles.Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Antibacterial activity against pathogenicFrontiers in microbiology · 2024
    Article
  11. Review
  12. Evaluation of silver bio-functionality in a multicellularFrontiers in cellular and infection microbiology · 2023
    Article
  13. Why Is Tantalum Less Susceptible to Bacterial Infection?Journal of functional biomaterials · 2022
    Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Moran Huang *Department of Orthopaedics, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.ORCID 0000-0001-6503-9078
Kai Ye *Department of Orthopaedics, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.
Tu Hu *Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Kexin LiuDepartment of General Practice, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.
Mengzhen YouDepartment of General Practice, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.
Lei WangDepartment of Orthopaedics, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.
Hui QinDepartment of Orthopaedics, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.ORCID 0000-0002-6369-7488
Shanghai Sixth People's Hospital · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDespite the extensive development of antibacterial biomaterials, there are few reports on the effects of materials on the antibacterial ability of the immune system, and in particular of neutrophils. In this study, we observe differences between the in vivo and in vitro anti-infective efficacies of silver nanoparticles (AgNPs). The present study was designed to further explore the mechanism for this inconsistency using ex vivo models and in vitro experiments.

methodsAgNPs were synthesized using the polyol process and characterized by transmission electron microscopy and X-ray photoelectron spectroscopy. The antibacterial ability of AgNPs and neutrophils was tested by the spread-plate method. The infected air pouch model was prepared to detect the antimicrobial ability of AgNPs in vivo. Furthermore, blood-AgNPs-bacteria co-culture model and reactive oxygen species (ROS) measurement were used to evaluate the effect of AgNPs to neutrophil-mediated phagocytosis and ROS production.

resultsThe antibacterial experiments in vitro showed that AgNPs had superior antibacterial properties in cell compatible concentration. While, AgNPs had no significant antibacterial effect in vivo, and pathological section in AgNPs group indicated less neutrophil infiltration in inflammatory site than

conclusionThis study selects AgNPs as the representative of inorganic nano-biomaterials and reveals the phenomenon and the mechanism underlying the significant AgNPs-induced inhibition of the antibacterial ability of neutrophils, and may have a certain enlightening effect on the development of biomaterials in the future. In the fabrication of antibacterial biomaterials, however, attention should be paid to both cell and immune system safety to make the antibacterial properties of the biomaterials and innate immune system complement each other and jointly promote the host's ability to resist the invasion of pathogenic microorganisms.

Indexed as

AnimalsAnti-Bacterial AgentsCell MovementCell SurvivalDisease Models, AnimalFemaleHumansImmune SystemImmunity, InnateInflammation MediatorsMetal NanoparticlesMicrobial Sensitivity TestsNeutrophilsPhagocytosisRatsRats, Sprague-DawleyAnti-Bacterial AgentsInflammation MediatorsReactive Oxygen SpeciesRNASilverSuperoxidesantibacterial biomaterialsimmune systempolymorphonuclear neutrophilssilver nanoparticles

Identifiers

PMID33633450
PMCPMC7901559
OpenAlexW3131401009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.